Atlas Trials

Mild Alzheimer's Disease

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Mild Alzheimer's Disease

RecordFirmDate
Lomecel-B Effects on Alzheimer's Disease (NCT05233774)Longeveron Inc.2021-12-28
A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. (NCT03752294)University of Rhode Island2019-05-01
Deferiprone to Delay Dementia (The 3D Study) (NCT03234686)Neuroscience Trials Australia2018-01-19
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease (NCT03186989)Ionis Pharmaceuticals, Inc.2017-10-12
A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment (NCT01548287)AstraZeneca2012-04-01
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease (NCT01482013)High Point Pharmaceuticals, LLC.2011-10-01
An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease (NCT01013610)Link Medicine Corporation2009-11-01
Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment (NCT01061489)University of Konstanz2009-08-01
Effect of AQW051 in Patients With Memory Impairment (NCT00582855)Novartis Pharmaceuticals2007-12-01
Early Detection of Mild Cognitive Impairment in Individual Patients (NCT00243451)Louisiana State University Health Sciences Center Shreveport2003-09-01
Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients (NCT00706186)Clayton Sleep Insititute

Track Mild Alzheimer's Disease automatically

Every clearance here is in the API, with alerts when new ones post.